SCHEMBL6867255

SCHEMBL6867255

Cc1cc(NC2CCC(NC(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)CC2)nc2ccccc12

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 7/20 0.57
MCHR1 Q99705 7/20 0.57
LMNA P02545 3/20 0.56
KDM4E B2RXH2 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
ADRA1A P35348 2/20 0.53
HRH1 P35367 2/20 0.53
MAPT P10636 3/20 0.48
POLB P06746 1/20 0.48
HTR1A P08908 1/20 0.46
HTR2B P41595 1/20 0.46
NPY5R Q15761 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
TP53 P04637 2/20 0.45
RAB9A P51151 1/20 0.44
CRHR1 P34998 1/20 0.44
MAPK1 P28482 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6867248 1.00 ADRA2A (0.57) ADRA2AMCHR1LMNAKDM4ESMN1; SMN2
Hydrochloric Acid SCHEMBL6459511 0.99 ADRA2A (0.56) ADRA2AMCHR1LMNAKDM4ESMN1; SMN2
Hydrochloric Acid SCHEMBL6459506 0.99 ADRA2A (0.56) ADRA2AMCHR1LMNAKDM4ESMN1; SMN2
SCHEMBL6460116 0.92 ADRA2A (0.67) ADRA2AMCHR1LMNAKDM4ESMN1; SMN2
SCHEMBL6460123 0.92 ADRA2A (0.67) ADRA2AMCHR1LMNAKDM4ESMN1; SMN2
Hydrochloric Acid SCHEMBL6455250 0.91 ADRA2A (0.66) ADRA2AMCHR1LMNAKDM4ESMN1; SMN2
Hydrochloric Acid SCHEMBL6455255 0.91 ADRA2A (0.66) ADRA2AMCHR1LMNAKDM4ESMN1; SMN2
SCHEMBL6461614 0.87 MCHR1 (0.61) ADRA2AMCHR1LMNAADRA1AHRH1
SCHEMBL6461619 0.87 MCHR1 (0.61) ADRA2AMCHR1LMNAADRA1AHRH1
SCHEMBL6458000 0.87 LMNA (0.59) ADRA2AMCHR1LMNAKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1464335-A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist Taisho Pharmaceutical Co. Ltd. (JP) 2004-10-06 EP disclosed